Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

NCT05680363 is registered in ClinicalTrials.gov with Fecundis S.A. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05680363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients
Lead sponsor
Fecundis S.A.
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2023
Completion date
December 18, 2025
Enrollment
41 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.